Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.
Erica BrivioEdoardo PennesiMarieke E WillemseAlwin D R HuitemaYilin JiangHarm D R van TinterenVincent H J van der VeldenH Berna BeverlooMonique L Den BoerLukas A J RammelooChad HudsonNyla HeeremaKarey KowalskiHuadong ZhaoLuke KuttschreuterFrancisco J Bautista SirventAndrew BukowinskiCarmelo RizzariJessica A PollardLaura MurilloMatthew KutnySara ZarnegarMichele S RedellStacy CooperYves BertrandArnaud PetitJulie I KrystalMarkus MetzlerDonna LancasterJean-Pierre BourquinJayashree MotwaniInge M Van der SluisFranco LocatelliMichael E RothNobuko HijiyaChristian Michel ZwaanPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
once daily (max 500 mg/d) with food in ND patients, which achieved targeted exposures as per adult experience.